Audiovisual Didactic Experience for Latino patient treatment Adherence and Non-English speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology

Contact:

NCT Number:

Protocol:

AAAT2490

Study Status:

Active/Enrolling

Population:

Adult

Phase:

II

In this study, you will be randomized to receive either a brochure or watch a video that discusses radiation and cancer clinical trials. In addition, you will complete questionnaires at seven time points: 1 questionnaire before radiotherapy, 4 questionnaires during the course of radiotherapy and 2 questionnaires at follow-up visits. The questionnaires and brochure or video administration will take place during your standard of care visits.

Are you Eligible? (Inclusion Criteria)

  • To be included in the main study, you must: 1. be age 18 years or older 2. be Spanish speaker of Latino Background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 3. have pathology proven diagnosis of prostate or breast cancer, with no metastasis 4. not have bilateral deafness or blindness

Specialty Area(s)

Breast Cancer, Prostate Cancer

Principal Investigator

Profile Headshot
  • Chair, Department of Radiation Oncology
  • Associate Director for Cancer Network Strategy in the Herbert Irving Comprehensive Cancer Center

Trial Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032